Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00148317 · FLOW

Participant flow

Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma · Source last updated 2017-07-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. id
    FG000
    title
    Overall Study
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        38
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        16
      type
      DOXIL Added at Cycle 3
    3. achievements
      1. group Id
        FG000
        num Subjects
        12
      type
      DOXIL Added at Cycle 5
    4. achievements
      1. group Id
        FG000
        num Subjects
        10
      type
      no DOXIL Added
    5. achievements
      1. group Id
        FG000
        num Subjects
        38
      type
      COMPLETED
    6. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Consolidation (VEL + DEX)
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        8
      type
      Adverse Event
    2. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Lack of Efficacy
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      unable to tolerate
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        38
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        27
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        11
      type
      NOT COMPLETED
    title
    Mobilization (VEL+CYTOXAN+FILGRASTIM)
Complete source fields
groups
  1. id
    FG000
    title
    Overall Study
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        38
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        16
      type
      DOXIL Added at Cycle 3
    3. achievements
      1. group Id
        FG000
        num Subjects
        12
      type
      DOXIL Added at Cycle 5
    4. achievements
      1. group Id
        FG000
        num Subjects
        10
      type
      no DOXIL Added
    5. achievements
      1. group Id
        FG000
        num Subjects
        38
      type
      COMPLETED
    6. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Consolidation (VEL + DEX)
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        8
      type
      Adverse Event
    2. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Lack of Efficacy
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      unable to tolerate
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        38
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        27
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        11
      type
      NOT COMPLETED
    title
    Mobilization (VEL+CYTOXAN+FILGRASTIM)

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice